A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/135
A61K 39/112 (2006.01) A61K 39/116 (2006.01) C12N 15/00 (2006.01)
Patent
CA 1241917
ABSTRACT OF THE DISCLOSURE A living, attenuated, oral vaccine system is described for the immunization against enteric disease. This oral vaccine is a genetic hybrid derivative of an attenuated galactose epimeraseless strain of S. typhi which carries at least one protective antigen other than normal somatic S. typhi antigens. The oral vaccine can provide protection against both typhoid fever and at least one other enteric disease. A bivalent oral vaccine is described wherein the non-typhoid protective antigen is the plasmid-encoded form I antigen of Shigella sonnei. A protective antigen from Shigella sonnei was transferred to a streptomycin resistant mutant of S. typhi strain Ty21a. The transconjugant S. typhi strain expressed both S. typhi and S. sonnei antigens and protected experimental animals against lethal infections with either S. typhi or S. sonnei. This strain is considered to be useful as a vaccine against typhoid fever and bacillary dysentery caused by S. sonnei.
408470
Baron Louis S.
Formal Samuel B.
Kopecko Dennis J.
Baron Louis S.
Formal Samuel B.
Kopecko Dennis J.
Smart & Biggar
LandOfFree
Oral vaccine for immunization against enteric disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral vaccine for immunization against enteric disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral vaccine for immunization against enteric disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1201151